As it continues to beef up its life sciences offerings, Baker McKenzie gained two new partners in its Washington, D.C., office this week, one of whom will lead the firm’s U.S. Food and Drug Administration practice.

In a busy week for lateral moves in the capital, Baker McKenzie also lost the former head of its Washington tax practice to Alston & Bird.